Ignite Creation Date:
2025-12-24 @ 3:57 PM
Ignite Modification Date:
2025-12-29 @ 12:57 AM
Study NCT ID:
NCT01497392
Status:
COMPLETED
Last Update Posted:
2022-07-22
First Post:
2011-02-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers
Sponsor:
Roswell Park Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2015-08-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-07
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-08
First Submit QC Date:
None
Study First Post Date:
2011-12-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-20
Last Update Post Date:
2022-07-22
Last Update Post Date Type:
ACTUAL